News
-
Ajinomoto Bio-Pharma Services Expands Manufacturing Agreement With AstraZeneca To Include Drug Product Manufacturing
3/30/2021
Ajinomoto Bio-Pharma Services, a leading provider of biopharmaceutical contract development and manufacturing services, announced a manufacturing agreement expansion with AstraZeneca to include drug product manufacturing.
-
Ajinomoto Bio-Pharma Services And Humanigen Expand Manufacturing Agreement To Support Fill Finish For Investigational COVID-19 Therapeutic, Lenzilumab, Nearing Completion Of Phase 3 Study
1/26/2021
Ajinomoto Bio-Pharma Services and Humanigen, Inc. today announced the companies will be expanding their manufacturing agreement for the fill finish supply of lenzilumab, which is one of the few Phase 3 treatment options in development for patients hospitalized with COVID-19.
-
Adare Pharma Solutions Opens New Small-Scale Laboratory To Offer Faster And More Efficient Development Capabilities To Clients
1/26/2021
Adare Pharma Solutions, a global technology-driven CDMO providing turnkey product development through commercial manufacturing expertise, is proud to announce the opening of a new small-scale development laboratory in Vandalia, Ohio.
-
Sharp Acquires US Pharmaceutical Packaging Facility
5/20/2020
Sharp, part of UDG Healthcare plc, a global leader in contract packaging and clinical supply services, has acquired a pharmaceutical packaging facility from Quality Packaging Specialists International, LLC (QPSI).